In Brief: Avobenzone
This article was originally published in The Tan Sheet
Executive Summary
Avobenzone: BASF expresses support for FDA's proposed GRAS/E designation of the sunscreen ingredient avobenzone in Oct. 17 comments ("The Tan Sheet" Sept. 23, p. 15). The company, however, complained that the omission of "foreign marketing experience with avobenzone...implicitly suggests that such data is inadequate." The comments assert that "FDA must accept foreign product marketing experience" and cite FDA's recent advance notice of proposed rulemaking that would allow foreign data based on "material time, material extent" criteria ("The Tan Sheet" Oct. 7, p. 1)...